Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -1.40M
June 30, 2026 -103.79M
March 31, 2026 -113.17M
December 31, 2025 -124.21M
September 30, 2025 -19.85M
June 30, 2025 -59.95M
March 31, 2025 -31.61M
December 31, 2024 -19.26M
September 30, 2024 -28.67M
June 30, 2024 11.70M
March 31, 2024 17.95M
December 31, 2023 4.796M
September 30, 2023 21.45M
June 30, 2023 31.48M
March 31, 2023 41.75M
December 31, 2022 234.74M
September 30, 2022 277.34M
June 30, 2022 410.79M
March 31, 2022 476.11M
December 31, 2021 514.74M
Date Value
September 30, 2021 554.12M
June 30, 2021 404.62M
March 31, 2021 326.62M
December 31, 2020 105.50M
September 30, 2020 -5.541M
June 30, 2020 -1.012M
March 31, 2020 3.984M
December 31, 2019 4.335M
September 30, 2019 5.567M
June 30, 2019 0.60M
March 31, 2019 0.331M
December 31, 2018 -2.997M
September 30, 2018 -3.573M
June 30, 2018 -4.619M
March 31, 2018 -4.588M
December 31, 2017 -1.564M
September 30, 2017 -0.798M
June 30, 2017 -0.618M
March 31, 2017 0.536M
December 31, 2016 0.617M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Quest Diagnostics, Inc. 1.375B
Labcorp Holdings, Inc. 1.287B
OPKO Health, Inc. -135.84M
Psychemedics Corp. --
NeoGenomics, Inc. -28.58M